Please try another search
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Andrew David William Newland | 59 | 2004 | Founder, CEO & Executive Director |
Ian Francis Griffiths | 56 | 2004 | CFO, Finance Director, Company Secretary & Executive Director |
Jan Groen | 61 | 2018 | Independent Non-Executive Director |
Clive Stanway | - | - | Member of Scientific Advisory Board |
Ashok Venkitaraman | - | - | Member of Scientific Advisory Board |
James M. Reuben | - | 2015 | Member of Scientific Advisory Board |
Daniel Costin Danila | - | 2015 | Member of Scientific Advisory Board |
Adrian Newland | - | - | Member of Scientific Advisory Board |
Brian Howlett | 78 | 2013 | Non-Executive & Senior Independent Director |
Harold Swerdlow | - | - | Member of Scientific Advisory Board |
Greg L. Shaw | - | - | Member of Scientific Advisory Board |
Joseph D. Khoury | - | 2018 | Member of Scientific Advisory Board |
Juliet Thompson | 57 | 2023 | Non-Executive Director |
Joseph E. Eid | 55 | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review